0

Journal Articles

in Adverse Drug Effects
 81-100 of 346 Articles
JAMA | 
Medical News and Perspectives |  December 19, 2012
Zolpidem Increases Patients’ Fall Risk, Study Shows
Rebecca Voelker, MSJ
JAMA. 2012;308(23):2447. doi:10.1001/jama.2012.128004.
JAMA | 
Original Contribution |  December 19, 2012
Long-term Use of Aspirin and Age-Related Macular Degeneration
Barbara E. K. Klein, MD, MPH; Kerri P. Howard, MS; Ronald E. Gangnon, PhD; et al.
JAMA. 2012;308(23):2469-2478. doi:10.1001/jama.2012.65406.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  December 10, 2012
The Risk of Hip Fracture After Initiating Antihypertensive Drugs in the Elderly
Debra A. Butt, MD, MSc, CCFP, FCFP; Muhammad Mamdani, PharmD, MPH; Peter C. Austin, PhD; et al.
Arch Intern Med. 2012;172(22):1739-1744. doi:10.1001/2013.jamainternmed.469.
INCLUDES: , Supplemental Content
JAMA Internal Medicine | 
Original Investigation |  December 10, 2012
Supratherapeutic Dosing of Acetaminophen Among Hospitalized Patients
Li Zhou, MD, PhD; Saverio M. Maviglia, MD, MS; Lisa M. Mahoney, RPh; et al.
Arch Intern Med. 2012;172(22):1721-1728. doi:10.1001/2013.jamainternmed.438.
JAMA Internal Medicine | 
Invited Commentary |  December 10, 2012
Using Health Information Technology to Improve Health Care: Emphasizing Speed to Value:  Comment on “Supratherapeutic Dosing of Acetaminophen Among Hospitalized Patients”
Walter H. Ettinger, MD, MBA
Arch Intern Med. 2012;172(22):1728-1729. doi:10.1001/2013.jamainternmed.607.
JAMA Internal Medicine | 
Original Investigation |  December 10, 2012
Enoxaparin Outcomes in Patients With Moderate Renal Impairment
Douglas D. DeCarolis, PharmD; Joey G. Thorson, PharmD; Megan A. Clairmont, PharmD; et al.
Arch Intern Med. 2012;172(22):1713-1718. doi:10.1001/2013.jamainternmed.369.
INCLUDES: CME
JAMA Internal Medicine | 
Invited Commentary |  December 10, 2012
Moderate Renal Impairment and Risk of Bleeding With Anticoagulation:  Comment on “Enoxaparin Outcomes in Patients With Moderate Renal Impairment”
Tracy Minichiello, MD
Arch Intern Med. 2012;172(22):1718-1720. doi:10.1001/2013.jamainternmed.456.
JAMA Dermatology | 
Observation |  December 01, 2012
Gefitinib-Induced Paronychia:  Response to Autologous Platelet-Rich Plasma
Soon-Hyo Kwon, MD; Jae-Woo Choi, MD; Jong-Soo Hong, MD; et al.
Arch Dermatol. 2012;148(12):1399-1402. doi:10.1001/archdermatol.2012.3022.
JAMA Surgery | 
Original Article |  December 01, 2012
Prospective Evaluation of Accuracy of Liver Biopsy Findings in the Identification of Chemotherapy-Associated Liver Injuries
Luca Viganò, MD; Nicoletta Ravarino, MD; Alessandro Ferrero, MD; et al.
Arch Surg. 2012;147(12):1085-1091. doi:10.1001/archsurg.2012.1867.
JAMA Surgery | 
Invited Critique |  December 01, 2012
Preoperative Biopsy Evaluation of Chemotherapy-Associated Liver Injuries:  Looking for a Needle in a Haystack?
Comment on “Prospective Evaluation of Accuracy of Liver Biopsy Findings in the Identification of Chemotherapy-Associated Liver Injury”
Timothy M. Pawlik, MD, MPH, PhD; Jean-Nicolas Vauthey, MD
Arch Surg. 2012;147(12):1092. doi:10.1001/archsurg.2012.1874.
JAMA Dermatology | 
Research Letters |  December 01, 2012
A New Spectrum of Skin Toxic Effects Associated With the Multikinase Inhibitor Vandetanib
Damien Giacchero, MD; Constanza Ramacciotti, MD; Jean Philippe Arnault, MD; et al.
Arch Dermatol. 2012;148(12):1418-1420. doi:10.1001/2013.jamadermatol.192.
JAMA Dermatology | 
Correspondence |  December 01, 2012
Hidradenitis Suppurativa, Eruptive Melanocytic Nevi, and Keratosis Pilaris–like Eruption in a Patient Treated With Vemurafenib
Liqiao Ma, BS; Arturo R. Dominguez, MD; George R. Collins, DO; et al.
Arch Dermatol. 2012;148(12):1428-1429. doi:10.1001/2013.jamadermatol.23.
JAMA Psychiatry | 
Original Article |  December 01, 2012
Neural Correlates of Weight Gain With Olanzapine
Jose Mathews, MD; John W. Newcomer, MD; Jennifer R. Mathews, PhD; et al.
Arch Gen Psychiatry. 2012;69(12):1226-1237. doi:10.1001/archgenpsychiatry.2012.934.
INCLUDES: , Supplemental Content
JAMA | 
Health Agencies Update |  November 28, 2012
Burns From Topical Pain Relievers
Bridget M. Kuehn, MSJ
JAMA. 2012;308(20):2073. doi:10.1001/jama.2012.76605.
JAMA | 
Health Agencies Update |  November 28, 2012
Eyedrop Risks for Kids
Bridget M. Kuehn, MSJ
JAMA. 2012;308(20):2073. doi:10.1001/jama.2012.76652.
JAMA | 
Health Agencies Update |  November 28, 2012
Drugs and Liver Injury
Bridget M. Kuehn, MSJ
JAMA. 2012;308(20):2073. doi:10.1001/jama.2012.76683.
JAMA | 
Medical News and Perspectives |  November 28, 2012
Consumer Group Asks FDA to Warn Patients About Hypertension Combination Therapy
Mike Mitka, MSJ
JAMA. 2012;308(20):2070-2071. doi:10.1001/jama.2012.25362.
JAMA | 
Viewpoint |  November 14, 2012
Prevention of Fatal Opioid Overdose
Leo Beletsky, JD, MPH; Josiah D. Rich, MD, MPH; Alexander Y. Walley, MD, MSc
JAMA. 2012;308(18):1863-1864. doi:10.1001/jama.2012.14205.
JAMA | 
Viewpoint |  November 14, 2012
Rethinking Opioid Prescribing to Protect Patient Safety and Public Health
G. Caleb Alexander, MD, MS; Stefan P. Kruszewski, MD; Daniel W. Webster, ScD, MPH
JAMA. 2012;308(18):1865-1866. doi:10.1001/jama.2012.14282.
JAMA Internal Medicine | 
Original Investigation |  November 12, 2012
Zonisamide for Weight Reduction in Obese Adults:  A 1-Year Randomized Controlled Trial
Kishore M. Gadde, MD; Mariko F. Kopping, MS, RD; H. Ryan Wagner, PhD; et al.
Arch Intern Med. 2012;172(20):1557-1564. doi:10.1001/2013.jamainternmed.99.
INCLUDES: , Supplemental Content

Sign In

Register for a FREE personal account

and access these and other features:

Register Now

Want to Subscribe?

Learn More about subscription options.

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

From The JAMA Network
JAMA
Original Contribution  |  May 01, 2013
Effect of Different Dosages of Oral Vitamin D Supplementation on Vitamin D Status in Healthy, Breastfed Infants:  A Randomized Trial
Sina Gallo, RD, MSc; Kathryn Comeau, RD, MSc; Catherine Vanstone, RN, MSc; et al.
JAMA
Original Contribution  |  April 24, 2013
Prenatal Valproate Exposure and Risk of Autism Spectrum Disorders and Childhood Autism
Jakob Christensen, PhD; Therese Koops Grønborg, MSc; Merete Juul Sørensen, PhD; et al.
JAMA
Editorial  |  April 24, 2013
Risks of In Utero Exposure to Valproate
Kimford J. Meador, MD; David W. Loring, PhD
JAMA
Health Agencies Update  |  April 24, 2013
Diabetes Drugs Investigated
Bridget M. Kuehn, MSJ
© 2013 American Medical Association. All Rights Reserved.
Powered bySilverchair Information Systems